-+ 0.00%
-+ 0.00%
-+ 0.00%

Evercore ISI Group Initiates Coverage On Beam Therapeutics with Outperform Rating, Announces Price Target of $35

Benzinga·11/24/2025 14:56:39
Listen to the news
Evercore ISI Group analyst Cory Kasimov initiates coverage on Beam Therapeutics (NASDAQ:BEAM) with a Outperform rating and announces Price Target of $35.